Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Sells Additional Stock to Offering Underwriters

Premium

Tekmira Pharmaceuticals this week said that the underwriters of its recent public stock offering of 3.75 million shares have exercised their over-allotment option to buy an additional 562,000 shares at $8 apiece.

With the additional stock sold, Tekmira raised a total of about $34.5 million in the transaction.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.